BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3299056)

  • 1. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation.
    Schneider MD; Perryman MB; Payne PA; Spizz G; Roberts R; Olson EN
    Mol Cell Biol; 1987 May; 7(5):1973-7. PubMed ID: 3299056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.
    Payne PA; Olson EN; Hsiau P; Roberts R; Perryman MB; Schneider MD
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8956-60. PubMed ID: 3122209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
    Olson EN; Spizz G; Tainsky MA
    Mol Cell Biol; 1987 Jun; 7(6):2104-11. PubMed ID: 3600660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression.
    Spizz G; Hu JS; Olson EN
    Dev Biol; 1987 Oct; 123(2):500-7. PubMed ID: 3477514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells.
    Falcone G; Gauzzi MC; Tatò F; Alemà S
    Ciba Found Symp; 1990; 150():250-8; discussion 258-61. PubMed ID: 2115425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
    Edmondson DG; Olson EN
    Genes Dev; 1989 May; 3(5):628-40. PubMed ID: 2473006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
    Gossett LA; Zhang W; Olson EN
    J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways.
    Hu JS; Olson EN
    J Biol Chem; 1988 Dec; 263(36):19670-7. PubMed ID: 2461941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc oncogene expression inhibits the initiation of myogenic differentiation.
    Denis N; Blanc S; Leibovitch MP; Nicolaiew N; Dautry F; Raymondjean M; Kruh J; Kitzis A
    Exp Cell Res; 1987 Sep; 172(1):212-7. PubMed ID: 2443373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of myogenic differentiation by cellular oncogenes.
    Schneider MD; Olson EN
    Mol Neurobiol; 1988; 2(1):1-39. PubMed ID: 3077064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic regulation of c-fos expression in cultured BC3H1 muscle cells.
    Barka T; van der Noen H; Gresik EW
    Exp Cell Res; 1989 Dec; 185(2):419-35. PubMed ID: 2557227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
    Spizz G; Roman D; Strauss A; Olson EN
    J Biol Chem; 1986 Jul; 261(20):9483-8. PubMed ID: 3722206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadmium induces transcription of proto-oncogenes c-jun and c-myc in rat L6 myoblasts.
    Jin P; Ringertz NR
    J Biol Chem; 1990 Aug; 265(24):14061-4. PubMed ID: 1696944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogens and oncogenes can block the induction of specific voltage-gated ion channels.
    Caffrey JM; Brown AM; Schneider MD
    Science; 1987 May; 236(4801):570-3. PubMed ID: 2437651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferin, a prolactin/growth hormone-like peptide represses myogenic-specific transcription by the suppression of an essential serum response factor-like DNA-binding activity.
    Muscat GE; Gobius K; Emery J
    Mol Endocrinol; 1991 Jun; 5(6):802-14. PubMed ID: 1656242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-ski proto-oncogene during cell cycle arrest and myogenic differentiation.
    Ambrose MR; Bottazzi ME; Goodenow MM
    DNA Cell Biol; 1995 Aug; 14(8):701-7. PubMed ID: 7646817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
    Ray R; Thomas S; Miller DM
    Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype.
    Endo T; Nadal-Ginard B
    Mol Cell Biol; 1986 May; 6(5):1412-21. PubMed ID: 2431278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.
    Sejersen T; Sümegi J; Ringertz NR
    J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.